文章摘要
徐智军,于 鹏,梁英魁,王政清,王玉华.放射性核素131I在甲亢治疗中的安全性与有效性[J].,2017,17(19):3762-3764
放射性核素131I在甲亢治疗中的安全性与有效性
Efficacy and Safety of Radionuclide 131I in the Treatment of Hyperthyroidism
投稿时间:2016-11-13  修订日期:2016-11-30
DOI:10.13241/j.cnki.pmb.2017.19.041
中文关键词: 放射性核素131I  甲亢  不良反应  甲状腺激素
英文关键词: Radionuclide 131I  Hyperthyroidism  Adverse reaction  Thyroid hormone
基金项目:
作者单位E-mail
徐智军 河北省唐山市中医医院 核医学科 河北 唐山 063000 xuzhijun_7612@medarticleonline.com 
于 鹏 华北理工大学附属医院核医学科 河北 唐山 063000  
梁英魁 海军总医院 核医学科 北京 100048  
王政清 河北省唐山市中医医院 核医学科 河北 唐山 063000  
王玉华 河北省唐山市中医医院 核医学科 河北 唐山 063000  
摘要点击次数: 197
全文下载次数: 83
中文摘要:
      摘要 目的:探讨放射性核素131I应用于甲亢治疗的安全性与有效性。方法:选择2013年8月到2016年2月选择在我院诊治的甲亢患者240例,根据随机信封抽签原则分为观察组与对照组各120例,对照组口服丙硫氧嘧啶片治疗,观察组在对照组治疗的基础上给予放射性核素131I治疗,治疗观察3个月,记录治疗的安全性与有效性。结果:治疗后,观察组总有效率为96.7%,明显高于对照组的86.7%(P<0.05)。观察组治疗后血清甲状腺激素水平明显低于治疗前及对照组(P<0.05)。观察组治疗期间的甲减、粒细胞减少、肝脏损害、贫血等不良反应发生率为11.7%,对照组为10.8%,两组不良反应的发生率对比差异无统计学意义(P>0.05)。结论:放射性核素131I可使甲亢患者的甲状腺激素的分泌和合成显著减少,安全性及有效性均较高。
英文摘要:
      ABSTRACT Objective: To explore the efficacy and safety of radionuclide 131I in the treatment of hyperthyroidism. Methods: From August 2013 to February 2016, 240 cases of patients with hyperthyroidism in our hospital were selected and randomly divided into the observation group and control group with 120 cases of patients in each group. The control group was treated with propylthiouracil tablets, while the observation group was given radionuclide 131I treatment based on the treatment of control group, all the patients were treated for 3 months, and the safety and efficacy were recorded. Results: The total effective rate of observation group and control group were 96.7% and 86.7% respectively, the total effective rate of observation group was significantly higher than that of the control group (P<0.05). After treatment, the serum levels of FT3 and FT4 in the observation group were significantly lower than those before treatment and those in the control group(P<0.05). The adverse reaction of observation group during the treatment included hypothyroidism, neutropenia, anemia, liver damage and the incidence rate was 11.7%, which was 10.8% in the control group, no significant difference was observed between two groups(P>0.05). Conclusion: Radionuclide 131I was safe and effective in the treatment of hyperthyroidism, which could reduce the se- cretion and synthesis of thyroid hormone.
查看全文   查看/发表评论  下载PDF阅读器
关闭